Hints and tips:
...payments are reflected in the operating activities section of our condensed consolidated statements of cash flows....
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...BUY: Smith & Nephew (SN.)...
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...But in his 18-month stint at Smith & Nephew, Mr Nawana oversaw a 40 per cent increase in its share price....
...Wirecard’s response Lawyers for Wirecard at Herbert Smith Freehills provided a statement in response to FT questions, which it said were fuelled by a “number of misunderstandings”: “Wirecard's corporate...
...FTSE 100 group Smith & Nephew had an even worse April than ITV. April revenues for the medical devices maker dropped 47 per cent, as elective surgeries have come to a halt in many countries....
...The lockdowns imposed to contain the virus are likely to have hit sales of drugs that need a doctor to administer them, while the delay in non-essential surgeries has hurt others including Smith & Nephew...
...Namal Nawana: competitive spirit UK medical devices maker Smith & Nephew seems keen to shift its listing to the US. That would give it a freer rein to raise the pay of chief exec Namal Nawana....
...A unit of Paul Singer’s aggressive activist fund Elliott Management has pushed for UK medical device maker Smith & Nephew to shed certain parts of its business, in a move that could make the company a more...
...European equities will be consolidated into a single team “whilst maintaining our strengths in non-European equities” Mr Jacob said....
...Smith & Nephew opens up the hunt Namal Nawana couldn’t have been more clear with his investors last week....
...Smith & Nephew, another Elliott target, jumped to a five-month high amid a retread of takeover speculation around the orthopaedic devices maker....
...Mr Nawana takes over as Smith & Nephew is facing pressure from activist investor Elliott Advisors, which has been pressing for divestments....
...” ● Alphavalue weighs up the chances of a bid approach for orthopaedics group Smith & Nephew on the back of reported stakebuilding in October by Elliott Management, the activist investor....
...Read more: Elliott urges Smith & Nephew to slim down business...
...Corporate earnings reports out today include Air France-KLM, Smith & Nephew, Société Générale and Repsol....
...A series of positive announcements from companies including International Consolidated Airlines, Marks & Spencer and Smith & Nephew weren’t enough to offset wider negativity on European stock markets this...
...for Smith & Nephew....
...Medical devices maker Smith & Nephew is planning to return $300m to shareholders through a share buyback, after agreeing to sell its gynaecology business to rival equipment maker, Medtronic....
...Its finance director Carol Fairweather was also replaced by Julie Brown, who joined from Smith & Nephew, the UK medical device company....
...Ze Frank, president of the BuzzFeed Motion Pictures, will lead the entertainment division, while BuzzFeed News will be consolidated under Ben Smith, the company’s editor and co-founder....
...Bookrunners such as BAML, Goldman and UBS may seek to price ConvaTec closer to Denmark’s Coloplast than Smith & Nephew of the UK....
...& Nephew also opposed the pay of its boss Olivier Bohuon....
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
International Edition